Related Experiment Video
Updated: Aug 6, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Off-pump revascularization for significant left ventricular dysfunction
Y Joseph Woo1, Todd J Grand, George P Liao
1Division of Cardiothoracic Surgery, Department of Surgery, University of Pennsylvania School of Medicine, 6 Silverstein Pavilion 3400 Spruce St., Philadelphia, PA 19104, USA. wooy@uphs.upenn.edu
Insights
Off-pump coronary artery bypass grafting (CABG) offers a safe revascularization alternative for patients with poor left ventricular function. This approach yields outcomes comparable to those with normal ventricular function, minimizing perioperative risks.
Area of Science:
- Cardiovascular Surgery
- Cardiac Anesthesia
- Heart Failure Research
Background:
- Left ventricular dysfunction (LVD) significantly increases perioperative risks in traditional on-pump coronary artery bypass grafting (CABG).
- Cardiopulmonary bypass and myocardial ischemia during on-pump CABG can exacerbate physiological insult in patients with compromised ventricular function.
Purpose of the Study:
- To evaluate the safety and efficacy of off-pump coronary artery bypass grafting (OPCAB) in patients with poor left ventricular ejection fraction (LVEF).
- To compare outcomes of OPCAB in patients with poor LVEF versus those with normal LVEF.
Main Methods:
- Retrospective analysis of non-emergency OPCAB procedures performed by a single surgeon over 18 months.
- Comparison of two groups: poor LVEF (10%-35%) and normal LVEF (55%-80%).
- Analysis of graft number, time to extubation, and length of hospital stay.
Main Results:
- Patients with poor LVEF (mean LVEF 26%) received 2.8 grafts/patient, were extubated in 8.4 hours, and discharged in 4.9 days.
- Outcomes in the poor LVEF group were statistically equivalent to the normal LVEF group (mean LVEF 63%).
- No intraaortic balloon pump insertion or mortality was observed in either group.
Conclusions:
- Off-pump coronary artery bypass grafting is an effective and safe revascularization strategy for patients with significant left ventricular dysfunction.
- OPCAB presents a valuable alternative for patients with ischemic cardiomyopathy and reduced LVEF, potentially avoiding the risks associated with cardiopulmonary bypass.
Abstract:
Left ventricular dysfunction is a predictor of perioperative morbidity and mortality in on-pump coronary artery bypass grafting. Obligatory global myocardial ischemia and injury induced during crossclamping as well as adverse systemic effects of cardiopulmonary bypass may induce a disproportionately greater overall physiologic insult in patients with poor ventricular function. All patients undergoing nonemergency off-pump coronary artery bypass by a single surgeon during an 18-month period were retrospectively analyzed. Two groups with preoperative ejection fraction classified as poor (10%-35%; n = 31) or normal (55%-80%; n = 60) were compared. The mean ejection fractions were 26% +/- 1% and 63% +/- 1% respectively, p < 0.000001. In those with significant left ventricular dysfunction, there were 2.8 +/- 0.1 grafts per patient, time to extubation was 8.4 +/- 1.2 hours, and discharge was after 4.9 +/- 0.6 days. These results were statistically equivalent to those in the group with normal left ventricular function. There was no intraaortic balloon pump insertion or mortality in either group. This technique provides an effective means of safely revascularizing patients with significant left ventricular dysfunction, and it may provide a valuable alternative approach in patients with ischemic cardiomyopathy.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Aortic Regurgitation III: Medical Management